HEPATIC Cause of oedema

Reading File

Finding Sources

Reading File

Loading Image

Reading File

Here is a thorough, textbook-grounded explanation of the hepatic cause of oedema:

Hepatic Cause of Oedema

Liver disease - most commonly cirrhosis - causes oedema through three interlinked mechanisms:

1. Hypoalbuminaemia → Reduced Plasma Oncotic Pressure

The liver is the sole site of albumin synthesis. In cirrhosis or fulminant hepatic failure, massive hepatocyte destruction sharply reduces albumin production.

Normal albumin synthesis: ~120 mg/kg/day; can double with low oncotic pressure, but a failing liver cannot compensate.
Albumin is the major osmotically active intravascular colloid. When serum albumin falls, plasma colloid osmotic (oncotic) pressure drops.
This allows fluid to leak out of capillaries into the interstitium, producing peripheral oedema (pitting, bilateral, dependent), and into the peritoneal cavity producing ascites.

"Hypoalbuminemia from decreased synthetic function in a cirrhotic liver results in reduced plasma oncotic pressure and contributes to the loss of fluid from the vascular compartment into the peritoneal cavity."

Harrison's Principles of Internal Medicine, 22e

"Because albumin is the osmotically active intravascular colloid, hypoalbuminemia often results in edema."

Henry's Clinical Diagnosis and Management by Laboratory Methods

2. Portal Hypertension → Increased Hydrostatic Pressure

In cirrhosis, fibrosis and nodular regeneration increase intrahepatic sinusoidal resistance, raising portal venous pressure. This elevated hydrostatic pressure in the portal system drives fluid outward into:

The peritoneal cavity (ascites)
The splanchnic interstitium

Portal hypertension also increases splanchnic lymph formation, further contributing to fluid accumulation.

According to Robbins Pathology (Table 3.1), liver cirrhosis is specifically listed under "Impaired Venous Return / Increased Hydrostatic Pressure" as a cause of oedema.

3. Splanchnic Vasodilation → Sodium and Water Retention

This is the underfilling hypothesis - a key mechanism in cirrhotic oedema:

Portal hypertension causes release of vasodilatory substances (especially nitric oxide) into the splanchnic circulation, causing splanchnic arterial vasodilation.
This creates "arterial underfilling" - the systemic circulation senses reduced effective arterial blood volume.
The body responds by activating the renin-angiotensin-aldosterone system (RAAS) and the sympathetic nervous system, resulting in avid renal sodium and water retention.
This expands extracellular fluid volume, perpetuating peripheral oedema and ascites.
The retained fluid continually leaks back out of the intravascular compartment, so the vascular "underfilling" sensation persists - creating a vicious cycle.

Pathogenesis of ascites in cirrhosis showing: Cirrhosis → Portal hypertension → Splanchnic vasodilation → increased splanchnic pressure + arterial underfilling → lymph formation + ascites formation, and sodium retention → plasma volume expansion

Development of ascites in cirrhosis - Harrison's Principles of Internal Medicine, 22e (Fig. 355-4)

Summary Table

Mechanism	Cause	Effect
Reduced albumin synthesis	Hepatocyte destruction	Low oncotic pressure → fluid leaks out
Portal hypertension	Sinusoidal fibrosis	Raised hydrostatic pressure → ascites, oedema
Splanchnic vasodilation + RAAS activation	Arterial underfilling	Na/water retention → extracellular fluid expansion
Increased hepatic lymph production	Obstruction of hepatic lymphatics	Ascites overflow

Clinical Presentation

In decompensated cirrhosis, the patient typically presents with:

Ascites (abdominal distension, shifting dullness, fluid thrill)
Bilateral pitting peripheral oedema (ankles, legs)
Hepatic hydrothorax (pleural effusion, usually right-sided, via diaphragmatic rent)
Anasarca in severe cases

The oedema fluid in hepatic disease is a transudate (protein-poor, low SAAG <11 g/L in non-portal causes, but SAAG ≥11 g/L in portal hypertension).

Sources: Robbins & Kumar Basic Pathology | Harrison's Principles of Internal Medicine, 22e | Henry's Clinical Diagnosis and Management by Laboratory Methods

invesigaion correlaion

Asking for Preferences

boh

Finding Sources

Reading File

Finding Sources

Reading File

Excellent material gathered. Here is the full integrated answer:

Investigations in Hepatic Oedema & Their Correlations

PART 1 - Lab Investigations & What Each Finding Means

A. Liver Function Tests (LFTs)

Investigation	Finding in Hepatic Disease	Correlation with Oedema/Liver Failure
Serum Albumin	Low (<3.5 g/dL)	Most direct correlate of oedema - reduced oncotic pressure → fluid leaks into interstitium and peritoneal cavity
AST / ALT	Elevated (ALT > AST in viral; AST > ALT in alcoholic)	Hepatocyte necrosis/inflammation; severe elevation → synthetic failure → low albumin
Serum Bilirubin	Elevated	Reflects excretory failure; rising level in cirrhosis = decompensation
Alkaline Phosphatase (ALP) + GGT	Elevated in cholestatic disease	Biliary obstruction/cholestasis
Prothrombin Time / INR	Prolonged	Most sensitive synthetic function marker; rises within hours of major hepatic insult; elevated INR = severe failure
Platelet count	Low (thrombocytopaenia)	Hypersplenism from portal hypertension - correlates with severity of portal HTN
Serum Sodium	Hyponatraemia (dilutional)	Seen in advanced cirrhosis with ascites; RAAS activation causes water retention
Serum Creatinine / Urea	Raised	May indicate hepatorenal syndrome in decompensated cirrhosis

"The initial evaluation of liver disease involves a battery of blood tests... assessing hepatic necroinflammation (aminotransferases), cholestatic biliary dysfunction (ALP, GGT), excretory function (bilirubin), and synthetic function (coagulation factors, albumin)."

Goldman-Cecil Medicine

B. Serum Albumin - Key Correlations with Oedema Severity

Serum Albumin Level	Interpretation	Clinical Oedema
3.5 - 5.0 g/dL	Normal	No oedema from hypoalbuminaemia
2.8 - 3.5 g/dL	Mild hypoalbuminaemia	Mild/early pitting oedema
<2.8 g/dL	Severe hypoalbuminaemia	Significant oedema + ascites likely
<2.0 g/dL	Critical	Anasarca; massive ascites; Child-Pugh score 3

PART 2 - Differentiating Hepatic vs Cardiac vs Renal Oedema

SAAG (Serum-Ascites Albumin Gradient)

The most reliable investigation: SAAG = Serum albumin - Ascites albumin

SAAG Value	Interpretation	Examples
≥ 1.1 g/dL	Portal hypertension (transudate)	Cirrhosis, cardiac failure, Budd-Chiari
< 1.1 g/dL	Non-portal cause (exudate)	Malignancy, TB peritonitis, nephrotic syndrome

"SAAG ≥1.1 g/dL has a diagnostic accuracy of 98% for portal hypertension-related ascites, compared to only 52-80% for other markers."

Henry's Clinical Diagnosis and Management by Laboratory Methods

Comparative Table - Hepatic vs Cardiac vs Renal Oedema

Feature	Hepatic	Cardiac	Renal (Nephrotic)
Serum albumin	Low (reduced synthesis)	Normal or mildly low	Very low (urinary loss)
Urinary protein	Normal/mild	Normal	>3.5 g/day (massive proteinuria)
AST/ALT	Elevated	Normal or mildly raised	Normal
INR/PT	Prolonged	Normal	Normal
Bilirubin	Elevated	Normal	Normal
BNP/NT-proBNP	Normal	Markedly elevated	Normal
Urine Na	Low (RAAS activation)	Low (RAAS activation)	Low (avid retention)
SAAG	≥1.1 (portal HTN)	≥1.1 (cardiac)	<1.1
Ascitic fluid protein	Low (<2.5 g/dL)	Low-medium	- (rarely ascites)
USS abdomen	Cirrhotic liver, splenomegaly, varices	Enlarged heart, bilateral pleural effusions	Normal liver
ECG/Echo	Normal	LV dysfunction, valvular disease	Normal

PART 3 - Severity Scoring: Child-Pugh Score

Used to grade hepatic oedema/cirrhosis severity and directly incorporates oedema-related parameters:

Component	1 point	2 points	3 points
Bilirubin	≤2 mg/dL	2-3 mg/dL	≥3 mg/dL
Serum Albumin	≥3.5 g/dL	2.8-3.5 g/dL	≤2.7 g/dL
INR	≤1.6	1.7-2.2	≥2.3
Ascites	None	Slight	Moderate-Massive
Encephalopathy	None	Grade 1-2	Grade 3-4
Class	A (5-6) = Compensated	B (7-9) = Moderate	C (10-15) = Decompensated

Sabiston Textbook of Surgery

The lower the albumin and the higher the bilirubin/INR, the more severe the synthetic failure - and the greater the degree of oedema and ascites.

MELD score additionally uses: Bilirubin + INR + Creatinine (+ Sodium in MELD-Na) - correlates with 90-day mortality in end-stage liver disease.

Summary: Investigation Correlation at a Glance

Low Albumin  →  ↓ Oncotic pressure  →  Oedema / Ascites
High INR     →  Coagulation failure → Synthetic dysfunction
High Bilirubin → Excretory failure  → Severity of disease
High SAAG (≥1.1) → Portal hypertension → Confirms hepatic/cardiac cause
Thrombocytopaenia → Hypersplenism    → Portal HTN marker
Low serum Na → RAAS activation     → Severe decompensation

This is a shared conversation. Sign in to Orris to start your own chat.